Evidence map›Paper›PMID 29632379›Full record

ArticleNature genetics2018

Regulatory variants at KLF14 influence type 2 diabetes risk via a female-specific effect on adipocyte size and body composition.

Kerrin S Small, Marijana Todorčević, Mete Civelek, Julia S El-Sayed Moustafa, Xiao Wang, Michelle M Simon, Juan Fernandez-Tajes, Anubha Mahajan, Momoko Horikoshi, Alison Hugill and 27 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Nature genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 100 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed, 6 pooled it
17.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 6 syntheses or guidelines pooled it, 199 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Review
  10. Choice of phenotype scale is critical in biobank-based G×E tests.bioRxiv : the preprint server for biology · 2026
    Article
  11. Genetic Variations inMolecular syndromology · 2025
    Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

37 authors at 12 institutions in 7 countries.

Kerrin S Small *Department of Twin Research and Genetic Epidemiology, King's College London, London, UK. kerrin.small@kcl.ac.uk.ORCID http://orcid.org/0000-0003-4566-0005
Marijana Todorčević *Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Oxford, UK.
Mete Civelek *Center for Public Health Genomics, Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, USA.ORCID http://orcid.org/0000-0002-8141-0284
Julia S El-Sayed Moustafa *Department of Twin Research and Genetic Epidemiology, King's College London, London, UK.
Xiao Wang *Cardiovascular Institute, Department of Medicine, Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Michelle M SimonBiocomputing, Medical Research Council Harwell Institute, Oxford, UK.
Juan Fernandez-TajesWellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Anubha MahajanWellcome Centre for Human Genetics, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-5585-3420
Momoko HorikoshiOxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Oxford, UK.
Alison HugillGenetics of Type 2 Diabetes, Medical Research Council Harwell Institute, Oxford, UK.
Craig A GlastonburyDepartment of Twin Research and Genetic Epidemiology, King's College London, London, UK.
Lydia QuayeDepartment of Twin Research and Genetic Epidemiology, King's College London, London, UK.
Matt J NevilleOxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Oxford, UK.ORCID http://orcid.org/0000-0002-6004-5433
Siddharth SethiBiocomputing, Medical Research Council Harwell Institute, Oxford, UK.
Marianne YonGenetics of Type 2 Diabetes, Medical Research Council Harwell Institute, Oxford, UK.
Calvin PanDepartment of Human Genetics, University of California, Los Angeles, Los Angeles, CA, USA.
Nam CheDepartment of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Ana ViñuelaDepartment of Twin Research and Genetic Epidemiology, King's College London, London, UK.ORCID http://orcid.org/0000-0003-3771-8537
Pei-Chien TsaiDepartment of Twin Research and Genetic Epidemiology, King's College London, London, UK.
Abhishek NagDepartment of Twin Research and Genetic Epidemiology, King's College London, London, UK.
Alfonso BuilDepartment of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland.ORCID http://orcid.org/0000-0002-1863-164X
Gudmar ThorleifssondeCODE Genetics, Reykjavik, Iceland.
Avanthi RaghavanHarvard Medical School, Boston, MA, USA.
Qiurong DingCAS Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, PR China.
Andrew P MorrisWellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Jordana T BellDepartment of Twin Research and Genetic Epidemiology, King's College London, London, UK.
Unnur ThorsteinsdottirdeCODE Genetics, Reykjavik, Iceland.
Kari StefanssondeCODE Genetics, Reykjavik, Iceland.
Markku LaaksoInstitute of Clinical Medicine, Internal Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.
Ingrid DahlmanDepartment of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
Peter ArnerDepartment of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
Anna L GloynOxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Oxford, UK.ORCID http://orcid.org/0000-0003-1205-1844
Kiran MusunuruCardiovascular Institute, Department of Medicine, Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Aldons J LusisDepartment of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Roger D CoxGenetics of Type 2 Diabetes, Medical Research Council Harwell Institute, Oxford, UK.ORCID http://orcid.org/0000-0001-7170-5014
Fredrik KarpeOxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Oxford, UK.
Mark I McCarthyOxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Oxford, UK. mark.mccarthy@drl.ox.ac.uk.ORCID http://orcid.org/0000-0002-4393-0510
King's College London · GBCentre for Human Genetics · GBMedical Research Council · GBUniversity of California, Los Angeles · USChurchill Hospital · GBdeCODE Genetics (Iceland) · ISKarolinska Institutet · SEUniversity of Pennsylvania · USChinese Academy of Sciences · CNHarvard University · USUniversity of Eastern Finland · FIUniversity of Geneva · CH

Funding

Systems genomics of metabolic syndrome traitsP01HL028481 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI REUE, KAREN · 1985 to 2019
$50.2M
Integrating genome-scale data to reveal causal mechanisms in type 2 diabetesU01DK105535 · NIDDK · UNIVERSITY OF OXFORD · PI GLOYN, ANNA LOUISE · 2015 to 2019
$1.7M
Functional studies of KLF14, a putative master regulator of metabolismR01DK099571 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI MUSUNURU, KIRAN · 2015 to 2018
$1.5M
Lifespan Psychosocial Profiles and Biological Pathways to Bone StrengthR01AG033067 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CRANDALL, CAROLYN JANET, KARLAMANGLA, ARUN S · 2009 to 2012
$1.4M
Systems genetics analysis of cardiometabolic trait loci in humans R00HL121172 · NHLBI · UNIVERSITY OF VIRGINIA · PI CIVELEK, METE · 2016 to 2018
$741k
British Heart Foundation RG/17/1/32663Medical Research Council MC_U142661184Medical Research Council MR/J010642/1Medical Research Council MR/L01999X/1Medical Research Council MR/L020149/1NHLBI NIH HHS P01 HL028481NHLBI NIH HHS R00 HL121172NIA NIH HHS R01 AG033067NIDDK NIH HHS R01 DK099571NIDDK NIH HHS U01 DK105535Wellcome Trust 200837/Z/16/Z
6 · The paper itself

Abstract

Individual risk of type 2 diabetes (T2D) is modified by perturbations to the mass, distribution and function of adipose tissue. To investigate the mechanisms underlying these associations, we explored the molecular, cellular and whole-body effects of T2D-associated alleles near KLF14. We show that KLF14 diabetes-risk alleles act in adipose tissue to reduce KLF14 expression and modulate, in trans, the expression of 385 genes. We demonstrate, in human cellular studies, that reduced KLF14 expression increases pre-adipocyte proliferation but disrupts lipogenesis, and in mice, that adipose tissue-specific deletion of Klf14 partially recapitulates the human phenotype of insulin resistance, dyslipidemia and T2D. We show that carriers of the KLF14 T2D risk allele shift body fat from gynoid stores to abdominal stores and display a marked increase in adipocyte cell size, and that these effects on fat distribution, and the T2D association, are female specific. The metabolic risk associated with variation at this imprinted locus depends on the sex both of the subject and of the parent from whom the risk allele derives.

Indexed as

AdipocytesAllelesAnimalsBody CompositionBody Fat DistributionCell SizeDiabetes Mellitus, Type 2Enhancer Elements, GeneticFemaleGene ExpressionGenome-Wide Association StudyGenomic ImprintingHumansKruppel-Like Transcription FactorsLipogenesisMaleKLF14 protein, humanKlf14 protein, mouseKruppel-Like Transcription FactorsSp Transcription Factors

Identifiers

PMID29632379
PMCPMC5935235
OpenAlexW2796811655

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.